![(1R)-9-[(1,3-dimethylazetidin-3-yl)(methyl)amino]-1-methyl-8-phenyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1H)-one in PDB entry 4ra5, assembly 1, side view.](https://www.ebi.ac.uk/pdbe/static/entry/4ra5_entity_2_side_image-200x200.png "Homo dimeric assembly 1 of PDB entry <span class='highlight'>4ra5</span> contains 2 copies of <span class='highlight'>(1R)-9-[(1,3-dimethylazetidin-3-yl)(methyl)amino]-1-methyl-8-phenyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1H)-one</span>. Side view.")
![(1R)-9-[(1,3-dimethylazetidin-3-yl)(methyl)amino]-1-methyl-8-phenyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1H)-one in PDB entry 4ra5, assembly 1, top view.](https://www.ebi.ac.uk/pdbe/static/entry/4ra5_entity_2_top_image-200x200.png "Homo dimeric assembly 1 of PDB entry <span class='highlight'>4ra5</span> contains 2 copies of <span class='highlight'>(1R)-9-[(1,3-dimethylazetidin-3-yl)(methyl)amino]-1-methyl-8-phenyl-3,5-dihydro[1,2,4]triazino[3,4-c][1,4]benzoxazin-2(1H)-one</span>. Top view.")
Environment details NEW
3L0 801 bound to chain A
The above 2D and 3D (Mol*) views of ligand interactions use quaternary structure derived from the PDB entry.
Please note:
Please note:
- Some chain IDs in the tooltip are followed by a number in square brackets. This number corresponds to the operation ID (mmCIF ‘oper_expression’) used to transform the chain.
- The structure seen in Mol* (3D view) was protonated using ChimeraX.
- Interactions were calculated using Arpeggio (see details for interaction types).
- The colour scheme used is consistent with Clustal X.